Key statistics
On Tuesday, Innoviva Inc (INVA:NSQ) closed at 22.41, -10.88% below its 52-week high of 25.15, set on Feb 26, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 22.41 |
|---|---|
| High | 22.71 |
| Low | 22.17 |
| Bid | -- |
| Offer | -- |
| Previous close | 22.32 |
| Average volume | 780.34k |
|---|---|
| Shares outstanding | 74.07m |
| Free float | 73.33m |
| P/E (TTM) | 7.24 |
| Market cap | 1.66bn USD |
| EPS (TTM) | 3.10 USD |
Data delayed at least 15 minutes, as of Mar 10 2026 20:00 BST.
More ▼
- Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
- Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
- Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea
